Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Long Term Incentive Plan Second Vesting

25 Jun 2019 09:17

RNS Number : 3256D
Biome Technologies PLC
25 June 2019
 

 

 

 

25 June 2019

Biome Technologies plc

("Biome", "the Company" or "the Group")

 

Long Term Incentive Plan (the "2017 LTIP") Second Vesting

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, announces that pursuant to the Company's 2017 LTIP, the second vesting of options has occurred.

 

The 2017 LTIP was announced on 21 December 2017 setting share performance hurdles to achieve the vesting of options thereby further aligning the interests of the Company's management with Biome's shareholders. Details of the second vesting of the 2017 LTIP, which occurred on 10 June 2019, can be found below, with the following options now having vested and are available to be exercised under the terms of the rules of the scheme.

 

 

Name of Individual

 

Options vested and available for exercise

 

Exercise price per share

Paul Mines (Director)

17,304

215 pence

Declan Brown (Director)

8,075

215 pence

Other Employees

10,382

215 pence

Total

35,761

 

 

The Company also announced on 21 December 2017 that an award had been made to John Standen, subject to the same performance criteria as the 2017 LTIP. Under this scheme no additional amount is payable to Mr Standen in respect of the second vesting on 10 June 2019.

 

 

 

-Ends-

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

 

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and that are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited. Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil-based polymers. Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

In 2018, the Board adopted the following three high level KPIs for the next three years to continue its ambitious momentum:

· Compound revenue growth of 25% per annum across the Group and 40% compound revenue growth in the Bioplastics division

· Diversify the Group's turnover by product and market to ensure that no one product or end customer contributes more than 15% of revenues by 2020

· Increase investment in the Group's next generation of products by spending significantly more per annum on average than the £0.3m per annum average spend over the previous strategic objective cycle

 

www.biometechnologiesplc.com

www.biomebioplastics.com and www.thinkbioplastic.com 

www.stanelcorftechnologies.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCMMGZVRKDGLZG
Date   Source Headline
18th Apr 202310:49 amRNSCompletion of CLN Fundraising
17th Apr 202311:30 amRNSResult of General Meeting
31st Mar 202311:14 amRNSProposed issue of Convertible Loan Notes
25th Jan 20237:00 amRNSTrading Update
16th Nov 20227:00 amRNSBiome receives £282k grant
10th Nov 202211:05 amRNSSecond Price Monitoring Extn
10th Nov 202211:00 amRNSPrice Monitoring Extension
10th Nov 20227:00 amRNSTrading Update
18th Oct 20229:28 amRNSHolding(s) in Company
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
22nd Sep 20222:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20222:00 pmRNSPrice Monitoring Extension
22nd Sep 20229:05 amRNSSecond Price Monitoring Extn
22nd Sep 20229:00 amRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
5th Sep 20227:00 amRNSGrant funding from Innovate UK
2nd Aug 20228:59 amRNSTrading Update - Replacement
2nd Aug 20227:00 amRNSTrading Update
20th Apr 202212:01 pmRNSResult of Annual General Meeting
20th Apr 20227:00 amRNSTrading Update
30th Mar 20222:48 pmRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSNotice of AGM and 2021 Annual Report
24th Mar 20227:00 amRNSFinal Results 2021
27th Jan 20227:00 amRNSTrading Update
4th Jan 202210:33 amRNSFurther substantial contract win for RF Division
16th Dec 20218:41 amRNSContract
17th Nov 20217:00 amRNSTrading Update
9th Nov 202111:12 amRNSHolding(s) in Company
25th Oct 20217:00 amRNSUpdate re biodegradable tree shelters
15th Sep 20217:00 amRNSInterim Results
30th Jul 20219:47 amRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSTrading Update
1st Jul 20219:05 amRNSSecond Price Monitoring Extn
1st Jul 20219:00 amRNSPrice Monitoring Extension
1st Jul 20217:00 amRNSTrading Update
30th Jun 20215:00 pmRNSTotal Voting Rights
7th Jun 202110:50 amRNSHolding(s) in Company
2nd Jun 20217:00 amRNSIssue of Equity and TVR
28th May 20217:00 amRNSAward under 2017 Long Term Incentive Plan
30th Apr 20215:00 pmRNSTotal Voting Rights
27th Apr 20214:25 pmRNSHolding(s) in Company
21st Apr 202110:51 amRNSHolding(s) in Company
21st Apr 202110:19 amRNSResult of Annual General Meeting
21st Apr 20217:00 amRNSTrading Update
9th Apr 20211:40 pmRNSPDMR Shareholding and transaction in own shares
1st Apr 202110:04 amRNSIssue of equity and Transaction in own shares
29th Mar 20217:00 amRNSNotice of AGM and Annual Report
25th Mar 20217:01 amRNSFinal Results 2020
25th Mar 20217:00 amRNSAppointment of New Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.